Progress toward the synthesis of pyrimidodiazepine-based folates as potential inhibitors of glycinamide ribonucleotide formyltransferase

CHED 1314

Jay Lanham, Morin M. Frick, Zoeisha Chinoy, and Partha S. Ray, psray@westga.edu. Department of Chemistry, University of West Georgia, 1601 Maple Street, Carrollton, GA 30118
Glycinamide ribonucleotide formyltransferase (GARFT) catalyses the reaction between 10-formyl-5,6,7,8-tetrahydrofolic acid and glycinamide ribionucleotide (GAR) to give N-formylglycinamide ribonucleotide (FGAR). The formyl carbon of FGAR is destined to become the C-8 carbon atom of inosine monophosphate from which all purine nucleotides are derived. Consequently, GARFT is an attractive target site for anticancer chemotherapy. We have designed a series of pyrimido[4,5-e][1,4]diazepine-based folates as potential inhibitors of GARFT. We will report on our progress on developing synthetic methodology to access the pyrimidodiazepine heterocyclic system and our targets.
 

Undergraduate Research Poster Session: Medicinal
2:00 PM-4:00 PM, Monday, March 26, 2007 Hyatt Regency Chicago -- Riverside Center, Poster

Division of Chemical Education

The 233rd ACS National Meeting, Chicago, IL, March 25-29, 2007